Article info

Download PDFPDF
Telmisartan and ramipril were equivalent, but their combination increased adverse events in vascular disease or diabetes

Citation

Telmisartan and ramipril were equivalent, but their combination increased adverse events in vascular disease or diabetes

Publication history

  • First published October 3, 2008.
Online issue publication 
October 03, 2008

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.